Uniqure NV - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
QURE Nasdaq 8731 http://www.uniqure.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Uniqure NV

uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease - Sep 23rd, 2024 11:05 am
uniQure (NASDAQ:QURE) investors are sitting on a loss of 88% if they invested five years ago - Sep 13th, 2024 11:52 am
uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - Aug 15th, 2024 11:05 am
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Aug 3rd, 2024 1:05 pm
UniQure restructuring to claim 300 jobs - Aug 1st, 2024 4:51 pm
UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates - Aug 1st, 2024 12:25 pm
UniQure: Q2 Earnings Snapshot - Aug 1st, 2024 11:22 am
uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update - Aug 1st, 2024 11:05 am
Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High? - Jul 26th, 2024 1:55 pm
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen - Jul 23rd, 2024 11:05 am
uniQure’s shares soar on positive data for Huntington’s gene therapy - Jul 12th, 2024 11:12 am
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure - Jul 11th, 2024 1:12 pm
Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet - Jul 10th, 2024 1:55 pm
uniQure (QURE) Soars on New Huntington's Disease Study Data - Jul 10th, 2024 1:01 pm
uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains? - Jul 10th, 2024 9:49 am
Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE) - Jul 9th, 2024 1:35 pm
UniQure stock surges on data for Huntington’s gene therapy - Jul 9th, 2024 12:05 pm
uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease - Jul 9th, 2024 11:05 am
uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52% - Jul 1st, 2024 12:20 pm
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen - Jul 1st, 2024 11:05 am